Tranexamic acid in trauma: we need stronger global health policy.
José Caballero Alvarado;
Yashbir Dewan;
Hesham Fathy Elsayed;
Tamar Gogichaishvili;
Sanjay Gupta;
BJ Hunt;
Pius Iribhogbe;
Mario Izurieta;
Hussein Khamis;
Edward O Komolafe;
+10 more...
Jorge H Mejía Mantilla;
Jaime Miranda
;
Carlos H Morales Uribe;
Oluwole Olaomi;
Fatos Olldashi;
Pablo Perel
;
PV Ramana;
RR Ravi;
Ian Roberts;
Haleema Shakur
;
(2013)
Tranexamic acid in trauma: we need stronger global health policy.
BMJ (Clinical research ed), 347 (jul23 ).
f4593-.
ISSN 0959-8138
DOI: 10.1136/bmj.f4593
Tranexamic acid substantially reduces death in bleeding trauma patients. So why are the World Health Organization, the United Nations, the World Bank, and Unicef not ensuring global implementation, ask Ian Roberts and colleagues
Item Type | Article |
---|---|
Keywords | randomized controlled-trial, transfusion, mortality, crash-2, death, Antifibrinolytic Agents, therapeutic use, Health Policy, trends, Hemorrhage, drug therapy, mortality, Humans, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Survival Rate, Tranexamic Acid, therapeutic use, World Health, trends, Wounds and Injuries, drug therapy, mortality |
ISI | 322524400006 |
ORCID: https://orcid.org/0000-0002-4738-5468
ORCID: https://orcid.org/0000-0002-2342-301X
ORCID: https://orcid.org/0000-0002-6511-109X